Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.85 | N/A |
| PEG Ratio (TTM) | -6.64 | N/A |
| P/S Ratio (TTM) | 2.30 | N/A |
| P/B Ratio (TTM) | 3.10 | N/A |
| P/FCF Ratio (TTM) | 13.46 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.28 | N/A |
| Price to 5YR AVG FCF Ratio | 13.66 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.30% | N/A |
| ROE (TTM) | 17.65% | N/A |
| Net Profit Margin (TTM) | 12.18% | N/A |
| ROIC 5YR AVG | 15.35% | N/A |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.40% | 39.41% | 11.45% |
| Revenue | 4.01% | 1.21% | -11.22% |
| Net Income | -1.25% | 38.69% | 11.03% |
| Cash Flow | 139.10% | 11.61% | 320.24% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.38 | N/A |
| Quick Ratio (TTM) | 1.01 | N/A |
| D/E Ratio (TTM) | 0.74 | N/A |
| Interest Coverage (TTM) | 6.10 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.67 | N/A |
| LTL to 5YR AVG FCF | 2.81 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.94% | N/A |